Category: Top Story
-
AI momentum stocks retreat as earnings season sparks technology selloff
Technology shares linked to the artificial intelligence boom came under renewed pressure on Thursday, as another wave of corporate earnings prompted investors to take profits from some of the market’s biggest winners. The weakness spread across Asia before carrying into U.S. premarket trading, where several high-profile AI-related names extended recent declines. Storage stocks lead premarket…
-
Honeywell Aerospace shares tumble after company cuts 2026 guidance
Honeywell Aerospace (NASDAQ:HONAV) shares fell nearly 12% in premarket trading on Thursday after the aerospace manufacturer reduced its 2026 sales growth forecast and issued a full-year earnings outlook that came in well below Wall Street expectations. The aircraft engine, aerospace components and defence systems producer now expects organic sales growth of between 4% and 5%…
-
Western Digital beats forecasts and raises outlook, but shares fall in premarket trading
Western Digital Corporation (NASDAQ:WDC) reported better-than-expected fourth-quarter results on Wednesday, surpassing Wall Street estimates for both earnings and revenue. However, the storage technology company’s shares fell more than 14% in premarket trading on Thursday as investors were left unimpressed by its forward guidance despite it exceeding consensus forecasts. Adjusted earnings per share came in at…
-
Sandisk shares slide as cautious guidance overshadows strong AI-driven growth
Sandisk (NASDAQ:SNDK) shares fell in premarket trading on Thursday after the flash memory manufacturer issued first-quarter guidance that failed to meet investors’ elevated expectations, despite another quarter of exceptional growth fuelled by artificial intelligence demand. The company forecast fiscal first-quarter 2027 revenue of between $10.3 billion and $10.8 billion, broadly in line with market forecasts…
-
Moderna secures FDA approval for its first mRNA influenza vaccine
Moderna (NASDAQ:MRNA) announced on Thursday that the U.S. Food and Drug Administration has approved its influenza vaccine, mFLUSIVA, for adults aged 50 and over. The decision marks the company’s first mRNA-based flu vaccine and the fourth product from Moderna to receive FDA approval. The biotechnology group expects to begin distributing mFLUSIVA to selected U.S. retailers…
-
US futures steady as Iran negotiations, earnings and economic data dominate attention: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock index futures traded with little direction on Thursday as investors monitored diplomatic developments involving Iran, assessed another round of corporate earnings and looked ahead to key labour market data due later this week. At 01:17 ET (05:17 GMT), Dow Jones futures were up 122 points, or 0.2%, while S&P 500 futures also gained…
-
Dow Closes at Fresh Record as Healthcare Gains Offset an AI-Led Tech Retreat
U.S. stocks split down the middle on Wednesday as a rotation out of high-flying technology names met strength in healthcare and consumer stocks. The Dow Jones Industrial Average pushed to another all-time closing high, but the tech-heavy Nasdaq Composite slipped as chipmakers came under renewed pressure. The story of the day was earnings season: strong…
-
Markets in Motion: economic outlook supports broader sector rotation
Bruce Campbell examines the copper-gold ratio, insider activity and improving momentum across financials, industrials and other market sectors.
-
SpaceX slides as heavy AI investment overshadows strong quarterly results
SpaceX (NASDAQ:SPCX) shares dropped more than 12% in early trading on Wednesday after investors focused on the company’s soaring artificial intelligence spending, despite quarterly revenue exceeding expectations and management unveiling ambitious long-term growth plans. The decline followed the company’s first earnings report since its high-profile public listing in June, with investors expressing concern over the…
-
Disney shares rise after earnings beat despite slight revenue shortfall
Walt Disney Co. (NYSE:DIS) advanced nearly 5% in pre-market trading on Wednesday after reporting third-quarter adjusted earnings that comfortably exceeded analysts’ expectations, even though quarterly revenue came in slightly below forecasts. Investors welcomed the stronger profitability and the company’s decision to increase its share repurchase programme. Profit outperforms Wall Street forecasts Disney reported adjusted earnings…